QQQ   426.61 (-1.04%)
AAPL   168.20 (-0.70%)
MSFT   411.91 (-0.64%)
META   495.05 (-0.94%)
GOOGL   155.69 (+0.84%)
AMZN   181.23 (-1.14%)
TSLA   156.65 (-0.29%)
NVDA   845.45 (-3.28%)
AMD   155.00 (-5.18%)
NIO   3.94 (+3.41%)
BABA   68.96 (-0.93%)
T   16.14 (+0.31%)
F   12.04 (-0.41%)
MU   116.64 (-4.21%)
GE   155.47 (-0.82%)
CGC   6.41 (-4.33%)
DIS   113.22 (-0.58%)
AMC   2.98 (+9.56%)
PFE   25.43 (-1.01%)
PYPL   63.29 (-0.22%)
XOM   118.51 (-0.15%)
QQQ   426.61 (-1.04%)
AAPL   168.20 (-0.70%)
MSFT   411.91 (-0.64%)
META   495.05 (-0.94%)
GOOGL   155.69 (+0.84%)
AMZN   181.23 (-1.14%)
TSLA   156.65 (-0.29%)
NVDA   845.45 (-3.28%)
AMD   155.00 (-5.18%)
NIO   3.94 (+3.41%)
BABA   68.96 (-0.93%)
T   16.14 (+0.31%)
F   12.04 (-0.41%)
MU   116.64 (-4.21%)
GE   155.47 (-0.82%)
CGC   6.41 (-4.33%)
DIS   113.22 (-0.58%)
AMC   2.98 (+9.56%)
PFE   25.43 (-1.01%)
PYPL   63.29 (-0.22%)
XOM   118.51 (-0.15%)
QQQ   426.61 (-1.04%)
AAPL   168.20 (-0.70%)
MSFT   411.91 (-0.64%)
META   495.05 (-0.94%)
GOOGL   155.69 (+0.84%)
AMZN   181.23 (-1.14%)
TSLA   156.65 (-0.29%)
NVDA   845.45 (-3.28%)
AMD   155.00 (-5.18%)
NIO   3.94 (+3.41%)
BABA   68.96 (-0.93%)
T   16.14 (+0.31%)
F   12.04 (-0.41%)
MU   116.64 (-4.21%)
GE   155.47 (-0.82%)
CGC   6.41 (-4.33%)
DIS   113.22 (-0.58%)
AMC   2.98 (+9.56%)
PFE   25.43 (-1.01%)
PYPL   63.29 (-0.22%)
XOM   118.51 (-0.15%)
QQQ   426.61 (-1.04%)
AAPL   168.20 (-0.70%)
MSFT   411.91 (-0.64%)
META   495.05 (-0.94%)
GOOGL   155.69 (+0.84%)
AMZN   181.23 (-1.14%)
TSLA   156.65 (-0.29%)
NVDA   845.45 (-3.28%)
AMD   155.00 (-5.18%)
NIO   3.94 (+3.41%)
BABA   68.96 (-0.93%)
T   16.14 (+0.31%)
F   12.04 (-0.41%)
MU   116.64 (-4.21%)
GE   155.47 (-0.82%)
CGC   6.41 (-4.33%)
DIS   113.22 (-0.58%)
AMC   2.98 (+9.56%)
PFE   25.43 (-1.01%)
PYPL   63.29 (-0.22%)
XOM   118.51 (-0.15%)

Allogene Therapeutics (ALLO) Earnings Date, Estimates & Call Transcripts

$3.49
-0.01 (-0.29%)
(As of 03:22 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Mar. 14)
-$0.43 Beat By $0.04
Consensus EPS
(Mar. 14)
-$0.47
Skip Charts & View Estimated and Actual Earnings Data

ALLO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALLO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Allogene Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244($0.58)($0.44)($0.51)
Q2 20244($0.58)($0.46)($0.52)
Q3 20244($0.59)($0.48)($0.53)
Q4 20244($0.59)($0.50)($0.54)
FY 202416($2.34)($1.88)($2.08)
Q1 20251($0.50)($0.50)($0.50)
Q2 20251($0.51)($0.51)($0.51)
Q3 20251($0.50)($0.50)($0.50)
Q4 20251($0.51)($0.51)($0.51)
FY 20254($2.02)($2.02)($2.02)

ALLO Earnings Date and Information

Allogene Therapeutics last released its earnings data on March 14th, 2024. The reported ($0.43) earnings per share for the quarter, topping analysts' consensus estimates of ($0.47) by $0.04. The business earned $0.02 million during the quarter, compared to the consensus estimate of $0.05 million. Allogene Therapeutics has generated ($2.09) earnings per share over the last year (($2.09) diluted earnings per share). Earnings for Allogene Therapeutics are expected to remain at ($1.69) per share in the coming year. Allogene Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

Allogene Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)
------- 
3/14/2024Q4 2023($0.47)($0.43)+$0.04($0.35)$0.05 million$0.02 million
11/2/2023Q3 2023($0.53)($0.37)+$0.16($0.37)$0.05 million$0.04 million
8/2/2023Q2 2023($0.59)($0.53)+$0.06($0.53)$0.01 million$0.04 million    
5/3/2023Q1 2023($0.63)($0.68)($0.05)($0.68)$0.08 million$0.05 million    
2/28/2023Q4 2022($0.71)($0.66)+$0.05($0.66)$0.06 million$0.05 million    
11/2/2022Q3 2022($0.62)($0.58)+$0.04($0.58)$0.01 million$0.05 million    
8/9/2022Q2 2022($0.61)($0.52)+$0.09($0.52)$0.08 million$0.09 million      
5/4/2022Q1 2022($0.59)($0.56)+$0.03($0.56)$0.10 million$0.06 million      
2/23/2022Q4 2021($0.61)($0.54)+$0.07($0.54)-$0.05 million    
11/4/2021Q3 2021($0.56)($0.57)($0.01)($0.57)-$0.05 million    
8/3/2021Q2 2021($0.55)($0.53)+$0.02($0.53)$0.95 million$0.04 million    
5/4/2021Q1 2021($0.46)($0.25)+$0.21($0.25)$24.50 million$38.35 million  

Allogene Therapeutics Earnings - Frequently Asked Questions

When is Allogene Therapeutics's earnings date?

Allogene Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on ALLO's earnings history.

Did Allogene Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Allogene Therapeutics (NASDAQ:ALLO) reported ($0.43) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.47) by $0.04. Learn more on analysts' earnings estimate vs. ALLO's actual earnings.

How much revenue does Allogene Therapeutics generate each year?

Allogene Therapeutics (NASDAQ:ALLO) has a recorded annual revenue of $90,000.00.

How much profit does Allogene Therapeutics generate each year?

Allogene Therapeutics (NASDAQ:ALLO) has a recorded net income of -$327.27 million. ALLO has generated -$2.09 earnings per share over the last four quarters.

What is Allogene Therapeutics's EPS forecast for next year?

Allogene Therapeutics's earnings are expected to stay at ($1.69) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ALLO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners